How does a high LDL/HDL ratio affect heart disease risk?

A high LDL/HDL ratio significantly increases heart disease risk by promoting arterial plaque buildup and inflammation. The optimal ratio is below 2.5, with higher ratios indicating greater cardiovascular danger regardless of total cholesterol levels.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the LDL/HDL ratio and its importance

When it comes to assessing cardiovascular health, many people focus solely on their total cholesterol numbers. However, the ratio between low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol provides a more nuanced and accurate picture of heart disease risk. This ratio reveals the balance between harmful and protective cholesterol in your bloodstream, offering crucial insights that total cholesterol alone cannot provide.

The LDL/HDL ratio is calculated by dividing your LDL cholesterol level by your HDL cholesterol level. For example, if your LDL is 130 mg/dL and your HDL is 50 mg/dL, your ratio would be 2.6. This simple calculation can be a powerful predictor of cardiovascular events, often more so than looking at individual cholesterol values in isolation.

Why the ratio matters more than total cholesterol

Research has consistently shown that the LDL/HDL ratio is a superior predictor of heart disease compared to total cholesterol levels. You could have a normal total cholesterol level but still be at high risk if your ratio is unfavorable. Conversely, someone with slightly elevated total cholesterol might have a low risk if their HDL is high and their ratio is optimal.

LDL/HDL Ratio Risk Categories

LDL/HDL RatioRisk CategoryInterpretationRecommended Action
Below 2.0Below 2.0OptimalVery low cardiovascular riskMaintain healthy lifestyle
2.0-2.52.0-2.5Near OptimalLow cardiovascular riskContinue preventive measures
2.5-3.52.5-3.5Borderline HighModerate cardiovascular riskImplement lifestyle changes
Above 3.5Above 3.5High RiskHigh cardiovascular riskAggressive intervention needed

Risk categories based on major cardiovascular studies. Individual risk assessment should consider additional factors.

The ratio reflects the dynamic interplay between cholesterol transport and removal in your body. LDL carries cholesterol to your arteries, where it can accumulate and form plaques, while HDL removes excess cholesterol from your arteries and transports it back to your liver for disposal. When this balance tips too far toward LDL, your cardiovascular risk increases substantially.

What constitutes a high LDL/HDL ratio?

Understanding what constitutes a healthy versus high-risk LDL/HDL ratio is essential for assessing your cardiovascular health. Medical professionals use specific thresholds to categorize risk levels and guide treatment decisions.

Gender differences in ratio interpretation

It's important to note that optimal ratios can vary slightly between men and women. Women typically have higher HDL levels due to estrogen's protective effects, especially before menopause. This means that women often have lower LDL/HDL ratios naturally. After menopause, however, women's HDL levels tend to decrease while LDL increases, potentially worsening their ratio and increasing cardiovascular risk.

Men generally have lower HDL levels throughout their lives, making it crucial for them to maintain lower LDL levels to achieve a healthy ratio. This gender difference underscores the importance of personalized cardiovascular risk assessment and monitoring.

How a high ratio increases heart disease risk

A high LDL/HDL ratio accelerates the development of atherosclerosis, the underlying process behind most heart attacks and strokes. When LDL levels are high relative to HDL, more cholesterol-carrying particles infiltrate the arterial walls. Without sufficient HDL to remove this excess cholesterol, it accumulates and oxidizes, triggering an inflammatory response.

This inflammation attracts white blood cells that attempt to clear the oxidized LDL but instead become foam cells, forming the fatty streaks that eventually develop into atherosclerotic plaques. These plaques narrow arteries, reduce blood flow, and can rupture suddenly, causing heart attacks or strokes. The higher your LDL/HDL ratio, the faster this process occurs.

The role of particle size and density

Beyond the basic ratio, the size and density of LDL particles also influence cardiovascular risk. Small, dense LDL particles are more atherogenic than large, fluffy ones because they penetrate arterial walls more easily and are more prone to oxidation. A high LDL/HDL ratio often correlates with a predominance of these harmful small, dense LDL particles.

Advanced lipid testing can measure particle size and number, providing even more detailed risk assessment. Apolipoprotein B (ApoB) testing, which measures the number of atherogenic particles, offers additional insights beyond the standard ratio. Regular monitoring of these advanced markers can help optimize your cardiovascular health strategy.

Clinical significance and research findings

Multiple large-scale studies have validated the LDL/HDL ratio as a powerful predictor of cardiovascular events. The Framingham Heart Study, one of the longest-running cardiovascular studies, found that the LDL/HDL ratio was a better predictor of coronary heart disease than either measurement alone. Participants with ratios above 3.5 had significantly higher rates of heart attacks and cardiovascular deaths.

The INTERHEART study, which examined heart attack risk factors across 52 countries, identified the ApoB/ApoA1 ratio (closely related to LDL/HDL) as the strongest predictor of myocardial infarction. This finding held true across different ethnicities, ages, and both genders, highlighting the universal importance of cholesterol balance in cardiovascular health.

Risk stratification and treatment decisions

Clinicians use the LDL/HDL ratio alongside other risk factors to stratify patients and guide treatment decisions. A high ratio often prompts more aggressive interventions, including lifestyle modifications and potentially medication. The ratio also helps identify patients who might benefit from treatment despite having borderline individual cholesterol values.

Recent guidelines emphasize personalized risk assessment, considering the LDL/HDL ratio along with factors like age, blood pressure, smoking status, and family history. This comprehensive approach ensures that high-risk individuals receive appropriate preventive care, potentially preventing thousands of cardiovascular events annually.

Factors that influence your LDL/HDL ratio

Your LDL/HDL ratio is influenced by a complex interplay of genetic, lifestyle, and environmental factors. Understanding these influences empowers you to take control of your cardiovascular health through targeted interventions.

Dietary impacts on cholesterol balance

Diet plays a crucial role in determining your LDL/HDL ratio. Saturated fats, found in red meat and full-fat dairy products, tend to raise LDL levels more than HDL, worsening the ratio. Trans fats are even more harmful, simultaneously raising LDL and lowering HDL. Conversely, monounsaturated fats from olive oil, avocados, and nuts can improve your ratio by raising HDL while maintaining or lowering LDL.

Soluble fiber from oats, beans, and fruits helps lower LDL by binding to cholesterol in the digestive system. Omega-3 fatty acids from fatty fish not only lower triglycerides but can also modestly increase HDL levels. Plant sterols and stanols, found in fortified foods or supplements, compete with cholesterol for absorption, effectively lowering LDL levels.

Lifestyle factors beyond diet

Physical activity is one of the most effective ways to improve your LDL/HDL ratio. Regular aerobic exercise can increase HDL levels by 5-10% while modestly reducing LDL. Resistance training complements aerobic exercise by improving overall metabolic health and body composition, both of which influence cholesterol levels.

Smoking cessation dramatically improves the LDL/HDL ratio, as smoking both lowers HDL and makes LDL more atherogenic. Weight loss, particularly reduction of abdominal fat, improves insulin sensitivity and typically raises HDL while lowering LDL. Even modest weight loss of 5-10% can significantly improve your ratio.

Strategies to improve your LDL/HDL ratio

Improving your LDL/HDL ratio requires a multifaceted approach combining dietary changes, lifestyle modifications, and sometimes medical interventions. The good news is that many effective strategies can significantly improve your ratio within weeks to months.

Start with dietary modifications that have proven effects on cholesterol levels. Replace saturated fats with unsaturated fats, increase soluble fiber intake to 25-30 grams daily, and incorporate plant sterols through fortified foods or supplements. The Mediterranean diet pattern, rich in olive oil, nuts, fish, and vegetables, has consistently shown benefits for improving the LDL/HDL ratio.

Exercise prescription for optimal ratios

Aim for at least 150 minutes of moderate-intensity aerobic exercise weekly, or 75 minutes of vigorous exercise. High-intensity interval training (HIIT) may be particularly effective for raising HDL levels. Combine this with resistance training twice weekly to maximize metabolic benefits. Even breaking up sedentary time with short activity breaks can help maintain healthy cholesterol levels.

When medication becomes necessary

Despite lifestyle interventions, some individuals may need medication to achieve optimal LDL/HDL ratios. Statins remain the first-line therapy for lowering LDL, with some statins also modestly raising HDL. Newer medications like PCSK9 inhibitors can dramatically lower LDL in high-risk patients. For those needing HDL elevation, options include niacin (though its use has declined) and fibrates, particularly in patients with high triglycerides.

Monitoring and testing your cholesterol levels

Regular monitoring of your cholesterol levels is essential for maintaining cardiovascular health and tracking the effectiveness of your interventions. Traditional lipid panels measure total cholesterol, LDL, HDL, and triglycerides, allowing calculation of various ratios. However, advanced testing options now provide deeper insights into your cardiovascular risk profile.

The frequency of testing depends on your risk factors and current levels. If you have optimal levels and no risk factors, testing every 4-6 years may suffice. However, if you have elevated levels, are making lifestyle changes, or taking medications, more frequent monitoring every 3-6 months helps track progress and adjust strategies. At-home testing options now make it convenient to monitor your levels regularly without frequent doctor visits.

Advanced lipid testing options

Beyond standard lipid panels, advanced tests provide additional risk stratification. Apolipoprotein B (ApoB) measures the number of atherogenic particles, offering a more accurate risk assessment than LDL cholesterol alone. Lipoprotein(a) testing identifies genetic risk that doesn't respond to lifestyle changes but indicates need for aggressive LDL lowering. Particle size analysis distinguishes between harmful small, dense LDL and less atherogenic large particles.

These advanced markers are particularly valuable for individuals with family history of premature heart disease, those with borderline traditional lipid values, or when standard therapy isn't achieving goals. Combining traditional and advanced testing provides the most comprehensive cardiovascular risk assessment.

Taking action for better cardiovascular health

Understanding your LDL/HDL ratio is just the first step in optimizing your cardiovascular health. The real power comes from taking consistent action based on this knowledge. Whether through dietary changes, increased physical activity, stress management, or medical interventions when necessary, improving your ratio is achievable and can significantly reduce your heart disease risk.

Remember that cardiovascular health is a long-term investment. Small, sustainable changes often yield better results than dramatic short-term efforts. Work with healthcare providers to develop a personalized plan based on your specific risk factors and health goals. Regular monitoring helps you stay on track and celebrate improvements along the way.

By taking control of your LDL/HDL ratio today, you're not just improving numbers on a lab report – you're actively reducing your risk of heart attacks, strokes, and other cardiovascular events. Your future self will thank you for the preventive steps you take now to ensure a healthier, longer life.

References

  1. Millán, J., Pintó, X., Muñoz, A., et al. (2009). Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management, 5, 757-765.[PubMed]
  2. Yusuf, S., Hawken, S., Ôunpuu, S., et al. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet, 364(9438), 937-952.[PubMed][DOI]
  3. Castelli, W. P., Abbott, R. D., & McNamara, P. M. (1983). Summary estimates of cholesterol used to predict coronary heart disease. Circulation, 67(4), 730-734.[PubMed]
  4. Fernandez, M. L., & Webb, D. (2008). The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. Journal of the American College of Nutrition, 27(1), 1-5.[PubMed]
  5. Ridker, P. M., Rifai, N., Cook, N. R., Bradwin, G., & Buring, J. E. (2005). Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA, 294(3), 326-333.[PubMed][DOI]
  6. Arsenault, B. J., Rana, J. S., Stroes, E. S., et al. (2009). Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Journal of the American College of Cardiology, 55(1), 35-41.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my LDL/HDL ratio at home?

You can test your LDL/HDL ratio at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive cholesterol testing including LDL, HDL, ApoB, and ApoA measurements. The program provides regular testing every 3-6 months to track your progress.

What is the ideal LDL/HDL ratio?

The ideal LDL/HDL ratio is below 2.5, with optimal levels below 2.0. Ratios between 2.5-3.5 indicate moderate risk, while ratios above 3.5 suggest high cardiovascular risk. Women typically have slightly lower ratios due to higher HDL levels.

Can I improve my LDL/HDL ratio without medication?

Yes, many people can improve their ratio through lifestyle changes including adopting a Mediterranean-style diet, exercising regularly (150+ minutes weekly), losing excess weight, quitting smoking, and managing stress. These changes can improve your ratio by 20-30% or more.

How quickly can I see changes in my LDL/HDL ratio?

Dietary changes can begin affecting your cholesterol levels within 2-4 weeks, with more significant improvements seen after 6-12 weeks. Exercise effects on HDL may take 8-12 weeks to manifest. This is why regular testing every 3-6 months is recommended when making lifestyle changes.

Is the LDL/HDL ratio more important than total cholesterol?

Yes, research shows the LDL/HDL ratio is a better predictor of heart disease risk than total cholesterol. You can have normal total cholesterol but still be at high risk with a poor ratio, or have slightly elevated total cholesterol but low risk with a good ratio.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details